权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Acid-sensing channels as novel target for brain ischemia

酸感应通道作为脑缺血的新靶点

基本信息

批准号：
7657259
负责人：
ZHIGANG XIONG
金额：
$ 28.19万
依托单位：
LEGACY EMANUEL HOSPITAL AND HEALTH CENTER
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-07-01 至 2010-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7657259
关键词：
ASIC channel Acidosis Acids Adverse effects Aggressive behavior Amiloride Animal Model Animal Testing Animals Behavior Brain Brain Ischemia Brain region Cell Culture Techniques Cells Cerebellum Chemosensitization Clinical Clinical Trials Clinical Trials Design Collaborations Comorbidity Data Development Dose Drug Administration Routes Equation Equilibrium Excitatory Amino Acid Antagonists Experimental Models Failure Free Radical Scavengers Functional disorder Future Genes Glucose Glutamate Receptor Glutamates Goals Health Planning Hippocampus (Brain)Human Hyperactive behavior Imaging Techniques In Vitro Infarction Inhibitory Concentration 50 Injection of therapeutic agent Injury International Intervention Intracranial Hemorrhages Intramuscular Intravenous Ions Ischemia Ischemic Brain Injury Ischemic Neuronal Injury Ischemic Stroke Mediating Membrane Membrane Potentials Modeling Morbidity - disease rate Mus Neuroglia Neuronal Injury Neurons Neuroprotective Agents Oligodendroglia Oregon Oxygen Pathway interactions Patients Pattern Peptides Perfusion Peritoneal Permeability Pharmaceutical Preparations Play Preclinical Drug Evaluation Primates Property Proteins Protocols documentation Public Health Receptor Activation Regulation Rodent Rodent Model Role Route Safety Saints Small Interfering RNA Solutions Stroke Surface System Testing Therapeutic Therapeutic Intervention Time Toxic effect Toxin Translating Variant Venoms Widow analog base benzamil cell injury clinically relevant deprivation desensitization disability effective therapy extracellular human subject in vivo inhibitor/antagonist ion channel blocker knock-down knockout gene mortality mouse model neuroprotection new therapeutic target novel patch clamp pre-clinical preclinical study prevent public health relevance response small molecule stroke therapy success voltage white matter injury

项目摘要

DESCRIPTION (provided by applicant): Ischemic stroke is a leading course of mortality and morbidity, and the most common reason for long-term disabilities. Unfortunately there is still no effective treatment for stroke patients other than the use of thrombolitics which have limited time window and potential side effect of intracranial hemorrhage. It has been well-recognized for several decades that that intracellular Ca2+ accumulation, particularly through glutamate receptor activation, and the resultant Ca2+ toxicity, play an important role in ischemic brain injury. However, the recent clinical trials using glutamate antagonists and most recently free radical scavengers, have failed to show protection against ischemic injury. Although multiple factors may have contributed together to the failure of the trials, it is likely that glutamate-independent Ca2+ loading pathway(s) equally contribute to the Ca2+ toxicity in ischemia. Indeed, our recent studies in neuronal cell culture and in whole animal models of ischemia have demonstrated that activation of acid-sensing ion channels (ASICs), and subsequent Ca2+ entry are largely responsible for acidosis- mediated, glutamate receptor-independent ischemic brain injury. In cultured mouse cortical neurons, lowering pH activates amiloride-sensitive ASIC currents. In the majority of these neurons, ASICs are permeable to Ca2+, and activation of these channels induces increased concentration of intracellular Ca2+ ([Ca2+]i). Activation of ASICs by brief incubation of neurons with acidic solutions induces time-dependent cell injury in the presence of blockers for voltage-gated Ca2+ channels and the glutamate receptors. This acid-induced, glutamate-independent neuronal injury is, however, inhibited by blocking the ASICs, by reducing the extracellular [Ca2+], or by ASIC1 gene knockout. In in vivo mouse model of ischemia, ASIC1 blockade or ASIC1 gene knockout dramatically reduced infarct volume. These findings strongly suggest that ASICs may represent novel therapeutic targets for human stroke. Our objective is to extend our exciting findings in animal cells to human brain neurons to explore the role of ASICs in acidosis-mediated ischemic injury of human brain neurons. Our central hypothesis is that human brain neurons express ASICs. Activation of ASICs induces intracellular Ca2+ accumulation, which is involved in acidosis-mediated, glutamate-independent neuronal injury. Success of these studies is an important step for establishing ASICs as novel targets for human stroke therapy. PUBLIC HEALTH RELEVANCE: We plan to investigate novel mechanisms and strategies to prevent cell loss after stroke. Our previous findings strongly suggest that ASICs may represent novel therapeutic targets for human stroke. Success of these studies is an important step for establishing ASICs as novel targets for human stroke therapy.

描述（由申请人提供）：缺血性中风是死亡率和发病率的主要原因，也是导致长期残疾的最常见原因。遗憾的是，目前对于脑卒中患者，除了使用时间窗有限且有颅内出血潜在副作用的溶栓剂外，尚无有效的治疗方法。几十年来，人们已经充分认识到，细胞内Ca2+积累，特别是通过谷氨酸受体激活，以及由此产生的Ca2+毒性，在缺血性脑损伤中起着重要作用。然而，最近使用谷氨酸拮抗剂和自由基清除剂的临床试验未能显示出对缺血性损伤的保护作用。虽然多种因素可能共同导致了试验的失败，但很可能不依赖谷氨酸的Ca2+加载途径同样导致了缺血时Ca2+的毒性。事实上，我们最近在神经元细胞培养和全动物缺血模型中的研究表明，酸敏感离子通道（asic）的激活和随后的Ca2+进入在很大程度上是酸中毒介导的、不依赖谷氨酸受体的缺血性脑损伤的原因。在培养的小鼠皮质神经元中，降低pH可激活阿米洛利敏感的ASIC电流。在大多数这些神经元中，asic对Ca2+是可渗透的，这些通道的激活诱导细胞内Ca2+浓度增加（[Ca2+]i）。在电压门控Ca2+通道和谷氨酸受体阻滞剂存在的情况下，用酸性溶液短暂孵育神经元激活asic可诱导时间依赖性细胞损伤。然而，这种酸诱导的、不依赖谷氨酸的神经元损伤可以通过阻断asic、减少细胞外[Ca2+]或敲除ASIC1基因来抑制。在体内小鼠缺血模型中，ASIC1阻断或ASIC1基因敲除可显著减少梗死体积。这些发现强烈提示asic可能是人类中风的新治疗靶点。我们的目标是将我们在动物细胞中的激动人心的发现扩展到人脑神经元，以探索asic在酸中毒介导的人脑神经元缺血性损伤中的作用。我们的中心假设是人类大脑神经元表达asic。asic的激活诱导细胞内Ca2+积累，这涉及酸中毒介导的，不依赖谷氨酸的神经元损伤。这些研究的成功是建立asic作为人类中风治疗新靶点的重要一步。公共卫生相关性：我们计划研究预防中风后细胞丢失的新机制和策略。我们之前的研究结果强烈表明asic可能是人类中风的新治疗靶点。这些研究的成功是建立asic作为人类中风治疗新靶点的重要一步。